Unstable angina non ST elevation myocardial infarction anticoagulant therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
*[[warfarin]]. | *[[warfarin]]. | ||
These agents are also sometimes referred to as [[antithrombin]]s, although, it should be noted that they often inhibit one or more proteins in the coagulation cascade before [[thrombin]]. | These agents are also sometimes referred to as [[antithrombin]]s, although, it should be noted that they often inhibit one or more proteins in the coagulation cascade before [[thrombin]]. | ||
==Anticoagulant therapy in UA/NSTEMI== | ==Anticoagulant therapy in UA/NSTEMI== | ||
You can read in greater detail about each of the therapies below in greater detail by clicking on the link for that therapy. | *You can read in greater detail about each of the therapies below in greater detail by clicking on the link for that therapy. | ||
[[Unstable angina / NSTEMI unfractionated heparin therapy |Unfractionated Heparin]] | [[Unstable angina / NSTEMI low molecular weight heparin therapy |Low Molecular Weight Heparin]] | [[Unstable angina / NSTEMI direct thrombin inhibitors therapy |Direct Thrombin Inhibitors]] | [[Unstable angina / NSTEMI factor Xa inhibitors therapy |Factor Xa Inhibitors]] | [[Unstable angina / NSTEMI long term anticoagulation therapy |Long Term Anticoagulation]] | |||
*You can also read the '''ACC/AHA Guidelines for anticoagulation''' [[Unstable angina / NSTEMI ACC/AHA guidelines for anticoagulation therapy|here]] <ref name="pmid17692738">{{cite journal |author=Anderson JL, Adams CD, Antman EM, ''et al'' |title=ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine |journal=JACC |volume=50 |issue=7 |pages=e1–e157 |year=2007 |month=August |pmid=17692738 |doi:10.1016/j.jacc.2007.02.013 |url=}}</ref> | |||
==See Also== | ==See Also== |
Revision as of 05:23, 15 July 2011
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina non ST elevation myocardial infarction anticoagulant therapy On the Web |
FDA on Unstable angina non ST elevation myocardial infarction anticoagulant therapy |
CDC onUnstable angina non ST elevation myocardial infarction anticoagulant therapy |
Unstable angina non ST elevation myocardial infarction anticoagulant therapy in the news |
Blogs on Unstable angina non ST elevation myocardial infarction anticoagulant therapy |
to Hospitals Treating Unstable angina non ST elevation myocardial infarction anticoagulant therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Smita Kohli, M.D.
Overview
Anticoagulation, traditionally with unfractionated heparin (UFH), is a cornerstone of therapy for patients with Unstable angina/NSTEMI. Some of the agents available in this category include:
- unfractionated heparin,
- low molecular weight heparin,
- Direct Thrombin Inhibitors (e.g.,bivalirudin)
- Factor Xa Inhibitors (e.g.,fondaparinux), and
- warfarin.
These agents are also sometimes referred to as antithrombins, although, it should be noted that they often inhibit one or more proteins in the coagulation cascade before thrombin.
Anticoagulant therapy in UA/NSTEMI
- You can read in greater detail about each of the therapies below in greater detail by clicking on the link for that therapy.
Unfractionated Heparin | Low Molecular Weight Heparin | Direct Thrombin Inhibitors | Factor Xa Inhibitors | Long Term Anticoagulation
See Also
Sources
- The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [1]
References
- ↑ 1.0 1.1 Anderson JL, Adams CD, Antman EM; et al. (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". JACC. 50 (7): e1–e157. PMID 17692738. Text "doi:10.1016/j.jacc.2007.02.013 " ignored (help); Unknown parameter
|month=
ignored (help)